Clinica Baviera S.A. | Mid-cap | Healthcare
€43.90
-0.23%
| Clinica Baviera S.A Stock Comparison:
Clinica Baviera S.A vs Pangaea OncologyClinica Baviera S.A vs EuroEspes S.AClinica Baviera S.A vs Grifols, S.AClinica Baviera S.A vs LaboratoriosClinica Baviera S.A vs Almirall S.AClinica Baviera S.A vs IBEX 35 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 74.5M
Operating Income 14.8M 19.86%
Net Income 9.9M 13.34%

Balance Sheet Metrics

Total Assets 230.3M
Total Liabilities 118.9M
Shareholders Equity 111.4M
Debt to Equity 1.07

Cash Flow Metrics

Operating Cash Flow 18.1M
Free Cash Flow 19.1M

Revenue & Profitability Trend

Clinica Baviera S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i262.6M224.9M198.4M172.7M122.6M
Cost of Goods Sold i30.6M27.1M25.5M21.5M15.3M
Gross Profit i232.1M197.8M172.9M151.2M107.4M
Gross Margin % i88.4%88.0%87.1%87.6%87.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i35.5M26.2M28.2M23.2M15.0M
Other Operating Expenses i19.3M17.5M15.0M11.7M9.6M
Total Operating Expenses i54.8M43.6M43.2M34.9M24.6M
Operating Income i55.6M50.0M42.1M39.5M20.5M
Operating Margin % i21.2%22.2%21.2%22.8%16.7%
Non-Operating Items
Interest Income i296.5K151.3K67.2K3.2K8.0K
Interest Expense i1.2M571.7K418.8K458.3K535.1K
Other Non-Operating Income-----
Pre-tax Income i56.0M49.7M40.7M38.9M20.2M
Income Tax i14.9M12.9M10.5M11.0M6.1M
Effective Tax Rate % i26.5%26.0%25.9%28.2%30.0%
Net Income i41.1M36.7M30.1M27.9M14.1M
Net Margin % i15.7%16.3%15.2%16.2%11.5%
Key Metrics
EBITDA i76.8M67.2M57.0M53.5M34.3M
EPS (Basic) i€2.47€2.21€1.81€1.68€0.85
EPS (Diluted) i€2.47€2.21€1.81€1.68€0.85
Basic Shares Outstanding i1600144016302654163030081630300816300982
Diluted Shares Outstanding i1600144016302654163030081630300816300982

Income Statement Trend

Clinica Baviera S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i10.1M8.3M19.2M9.8M10.8M
Short-term Investments i28.4M42.9M19.8M22.5M16.1M
Accounts Receivable i4.0M3.0M2.8M3.4M2.3M
Inventory i3.3M2.5M2.2M1.9M1.6M
Other Current Assets1.5M1.0M584.4K270.4K457.7K
Total Current Assets i47.7M57.7M44.6M37.9M31.4M
Non-Current Assets
Property, Plant & Equipment i129.5M114.1M104.8M95.1M93.9M
Goodwill i65.3M32.0M29.7M30.2M29.8M
Intangible Assets i8.7M2.7M461.1K997.8K564.3K
Long-term Investments-----
Other Non-Current Assets----1
Total Non-Current Assets i164.0M120.9M105.5M95.9M89.5M
Total Assets i211.7M178.6M150.1M133.8M120.9M
Liabilities
Current Liabilities
Accounts Payable i17.2M15.5M15.6M13.0M9.9M
Short-term Debt i11.3M10.8M9.9M11.7M13.1M
Current Portion of Long-term Debt-----
Other Current Liabilities-1--644.8K-
Total Current Liabilities i50.4M45.3M41.0M35.9M32.3M
Non-Current Liabilities
Long-term Debt i52.1M36.7M38.0M39.9M41.7M
Deferred Tax Liabilities i914.0K513.8K260.1K292.4K346.9K
Other Non-Current Liabilities---644.8K-
Total Non-Current Liabilities i62.9M41.1M40.7M42.5M43.7M
Total Liabilities i113.3M86.4M81.7M78.4M76.0M
Equity
Common Stock i1.6M1.6M1.6M1.6M1.6M
Retained Earnings i40.2M36.0M29.5M27.4M13.9M
Treasury Stock i9.1M109.9K93.7K75.9K48.7K
Other Equity-----
Total Shareholders Equity i98.4M92.3M68.4M55.4M44.9M
Key Metrics
Total Debt i63.5M47.4M47.9M51.6M54.8M
Working Capital i-2.7M12.5M3.6M2.1M-970.0K

Balance Sheet Composition

Clinica Baviera S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i56.0M49.7M40.7M38.9M20.2M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-29.9K-745.4K-52.2K-1.2M112.3K
Operating Cash Flow i57.2M49.3M41.4M38.2M19.3M
Investing Activities
Capital Expenditures i-26.5M-22.7M-14.0M-10.6M-7.8M
Acquisitions i-11.1M-0-50.0K0
Investment Purchases i-14.2M-40.5M-24.5M-10.5M-13.6M
Investment Sales i30.6M18.7M25.9M4.0M383
Investing Cash Flow i-21.2M-44.5M-12.6M-17.1M-21.4M
Financing Activities
Share Repurchases i-10.2M-706.5K-617.4K-491.4K-190.7K
Dividends Paid i-25.9M-13.6M-17.2M-17.3M-
Debt Issuance i7.2M-079.8K10.0M
Debt Repayment i-2.5M-2.0M-6.1M-5.8M-5.9M
Financing Cash Flow i-25.5M-15.6M-23.3M-23.0M4.0M
Free Cash Flow i36.0M35.1M39.3M36.3M23.6M
Net Change in Cash i10.5M-10.8M5.5M-1.9M1.9M

Cash Flow Trend

Clinica Baviera S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 18.17
Forward P/E 24.77
Price to Book 7.83
Price to Sales 2.42
PEG Ratio 24.77

Profitability Ratios

Profit Margin 13.51%
Operating Margin 19.71%
Return on Equity 46.33%
Return on Assets 16.56%

Financial Health

Current Ratio 0.91
Debt to Equity 70.72
Beta 0.80

Per Share Data

EPS (TTM) €2.40
Book Value per Share €5.57
Revenue per Share €17.75

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
cbav698.2M18.177.8346.33%13.51%70.72
Pangaea Oncology 58.6M-3.22-29.97%-37.18%23.04
EuroEspes S.A 6.3M---73.83%91.78%0.70
Grifols, S.A 7.8B29.191.694.99%4.00%126.87
Laboratorios 2.7B20.564.8325.01%17.66%22.50
Almirall S.A 2.2B102.601.511.45%2.02%26.47

Financial data is updated regularly. All figures are in the company's reporting currency.